Janus kinase inhibitors: between prescription authorization and reimbursability

被引：0
|
作者：
Spinelli, F. R. [1 ]
Conti, F. [1 ,2 ]
Caporali, R.
Iannone, F. [3 ]
Cacciapaglia, F. [3 ]
机构：
[1] Sapienza Univ Rome, Rheumatol Unit, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy
[2] Univ Milan, Dept Clin & Community Sci, Rheumatol Unit, ASST Gaetano Pini CTO, Milan, Italy
[3] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Rheumatol Unit, Bari, Italy
来源：
REUMATISMO | 2023年 / 75卷 / 04期
关键词：
RHEUMATOID-ARTHRITIS; VENOUS THROMBOEMBOLISM; CARDIOVASCULAR EVENTS; PSORIATIC-ARTHRITIS; RISK; RECOMMENDATIONS;
D O I：
10.4081/reumatismo.2023.1627
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：161 / 166
页数：6
相关论文
共 50 条
  • [1] Patterns in the Prescription, the Denials of Coverage, and the Delays in Dispensation of Janus Kinase Inhibitors
    Riley, Thomas
    Dombrovsky, Igor
    George, Michael
    Baker, Joshua
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2028 - 2029
  • [2] Janus kinase inhibitors clear to land Janus kinase inhibitors in RA
    Aringer, Martin
    [J]. RHEUMATOLOGY, 2018, 57 (07) : 1131 - 1132
  • [3] Janus kinase inhibitors
    Ostermeier, E.
    Roll, P.
    Tony, H. -P.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2012, 71 (06): : 473 - 478
  • [4] Janus kinase inhibitors
    Witte, Torsten
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2022, 81 (02): : 94 - 99
  • [5] Pharmacology of Janus kinase inhibitors
    Solimani, F.
    Hilke, F. J.
    Ghoreschi, K.
    [J]. HAUTARZT, 2019, 70 (12): : 934 - 941
  • [6] Thromboembolism and Janus Kinase Inhibitors
    Fowzia Ibrahim
    David L. Scott
    [J]. Drug Safety, 2020, 43 : 831 - 833
  • [7] Itch and Janus Kinase Inhibitors
    Han, Yujin
    Woo, Yu Ri
    Cho, Sang Hyun
    Lee, Jeong Deuk
    Kim, Hei Sung
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103
  • [8] Thromboembolism and Janus Kinase Inhibitors
    Ibrahim, Fowzia
    Scott, David L.
    [J]. DRUG SAFETY, 2020, 43 (09) : 831 - 833
  • [9] Investigational Janus kinase inhibitors
    Tam, Constantine S.
    Verstovsek, Srdan
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (06) : 687 - 699
  • [10] Janus-Kinase-HemmerJanus kinase inhibitors
    E. Ostermeier
    P. Roll
    H.-P. Tony
    [J]. Zeitschrift für Rheumatologie, 2012, 71 : 473 - 478
12345